NCT02916602View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Hypertension
Interventions
DRUG

HCP1401

amlodipine, Losartan, Chlorthalidone FDC

DRUG

HCP0605

amlodipine, Losartan FDC

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02916602 - A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605 | Biotech Hunter | Biotech Hunter